What to Do When You Feel an Opioid Relapse Coming
DeBinge opioid transition: When travelling to DeBinge in The Bahamas for OLANI treatment, there is no requirement to complete a separate opioid-free waiting window before arrival. DeBinge uses a medically supervised 4-to-5-day buprenorphine transition. Buprenorphine is introduced to bridge the patient away from full-agonist opioids, stabilised and tapered over the first several days, and the O’Neil Long-Acting Naltrexone Implant is typically inserted around day 4 or 5 while buprenorphine is still being tapered. The planned overlap continues as buprenorphine clears and the implant gradually releases naltrexone. This pathway is clinician-supervised because mistimed naltrexone exposure can precipitate withdrawal.
Based on DeBinge’s clinical experience in The Bahamas since 2018, the implant typically provides its strongest craving and relapse-prevention support on average 9 months, while clinically meaningful opioid-receptor blockade may persist for longer, in some patients up to about 15 months. This longer blockade may continue to reduce opioid effects and overdose risk.
Ongoing recovery: The implant is not a cure. The DeBinge programme includes a full year of professional counselling after implantation to address the behavioural and psychological side of addiction.
Sometimes relapse does not feel sudden. A person may notice cravings becoming stronger, start thinking repeatedly about opioids, reconnect with previous contacts, miss treatment appointments or find themselves moving closer to situations where opioids are available. That period can be an opportunity to act before opioid use occurs.
Act early. Move away from immediate triggers and opioid access, tell a trusted person what is happening, contact your treatment provider or recovery support, follow your medication plan, make sure naloxone is available, and avoid being isolated if you believe you are close to using opioids.
If you have already obtained opioids, are actively planning to use, or feel unable to interrupt the situation on your own, seek professional treatment support urgently rather than waiting to see whether the craving passes.
Prepared for Medical Review
Dr Fergus Law, BSc, MBChB, FRCPsych
Consultant Psychiatrist specialising in substance misuse and addiction psychiatry.
This article has been prepared as an evidence-informed educational resource and is awaiting formal clinical approval. Until formal review has been completed, it should not be represented as medically reviewed.
View Dr Fergus Law’s professional profile
Relapse Risk Can Build Before the Drug Is Taken
Relapse is sometimes imagined as one sudden decision. In reality, risk may begin increasing hours, days or sometimes longer before opioid use occurs.
Cravings may become more persistent. Treatment appointments may start to feel less important. A person may revisit old contacts, spend more time alone, begin thinking about where opioids could be obtained or convince themselves that one use would be manageable.
None of these signs guarantees that relapse will occur.
They can, however, signal that the current recovery plan needs more support.
The goal is to change the situation while you still have options: increase support, reduce access, reconnect treatment and make the next few hours safer.
In This Guide
- Signs relapse risk may be rising
- What to do immediately
- Leave the triggering situation
- Tell someone
- Contact treatment
- Check the medication plan
- Respond to the craving
- Reduce access to opioids
- Keep naloxone available
- When risk becomes urgent
- If opioid use has already happened
- What to review afterward
- How family can help
- Frequently asked questions
- Clinical sources
What Can It Feel Like When an Opioid Relapse Is Getting Closer?
Relapse warning signs are individual. One sign by itself does not prove that opioid use is about to happen.
A pattern of changes can be more important than any single behaviour.
Opioids Are Taking Up More Mental Space
Thoughts about opioids become more frequent, harder to redirect or increasingly connected with imagined relief.
Appointments Start Being Missed
Counselling, medication or clinical follow-up begins to feel less important or increasingly inconvenient.
Previous Opioid Networks Reappear
You begin checking messages, contacting previous suppliers or spending time with people strongly associated with opioid use.
You Return to High-Risk Places
You start visiting locations repeatedly associated with obtaining or using opioids.
One Use Starts to Feel Manageable
Thoughts may shift from “I cannot use” toward “I could use once,” “I can control it now,” or “nobody would know.”
You Pull Away From Support
Family, treatment providers or recovery contacts may hear less from you as relapse risk increases.
Stress or Mental Health Worsens
Depression, anxiety, anger, trauma symptoms, loneliness or severe sleep disruption may reduce coping capacity.
You Begin Moving Toward Access
Searching for opioids, obtaining money, arranging transport or contacting someone who can supply opioids marks a higher-risk stage.
What to Do in the Next Hour When Relapse Feels Close
The immediate aim is to create distance between the urge and access to opioids while bringing more support into the situation.
Stop moving toward opioids
If you are travelling toward a supplier, high-risk location or situation connected with opioid use, interrupt that movement where safely possible.
Leave the trigger
Move away from the person, place or situation intensifying the craving whenever doing so is safe and practical.
Tell another person what is happening
Contact someone you trust and say clearly that your relapse risk is increasing rather than trying to manage it secretly.
Contact treatment support
Reach your clinician, counsellor, treatment program or another established recovery support and explain that opioid use feels increasingly likely.
Check your medication plan
Continue prescribed medication as directed and obtain clinical advice if doses have been missed or treatment has been interrupted.
Make sure naloxone is available
Where opioid exposure is possible, keep naloxone accessible and make sure the people with you know where it is.
Avoid isolation when risk is high
If you believe you are close to using opioids, consider staying with a trusted supportive person while you reconnect with treatment.
Escalate support instead of waiting
If you have already obtained opioids, are actively arranging to obtain them, or feel unable to remain safe from opioid use, seek urgent professional treatment support.
Do Not Test Your Willpower by Staying Inside the Trigger
People sometimes try to prove recovery by remaining in a situation that is producing increasingly strong opioid thoughts.
That is not necessary.
If a particular person, place or situation is rapidly increasing the urge to use opioids, changing the environment may be one of the fastest available interventions.
If the Trigger Is a Person
End or postpone the interaction and move toward someone connected with recovery rather than opioid use.
If the Trigger Is a Place
Leave the location rather than remaining there to see whether the craving gets stronger.
If the Trigger Is Conflict
Create enough distance to reduce immediate emotional escalation before trying to resolve the disagreement.
If the Trigger Is Isolation
Move toward safe social contact, treatment support or another planned recovery environment.
Tell Someone Before Opioid Use Happens
As relapse risk rises, people may begin hiding cravings because they fear disappointing family, treatment providers or themselves.
Secrecy can remove exactly the support that might help interrupt the progression toward use.
The conversation does not need to be complicated.
“My cravings are much stronger today. I am thinking seriously about opioids and I need help changing what is happening before I use.”
The person you contact may be a clinician, counsellor, sponsor, peer-support contact, partner, parent, sibling or another trusted individual who understands the recovery plan.
The purpose is to increase support, not to hand another person total responsibility for your recovery.
Contact the Treatment Team Before the Situation Becomes More Difficult
Stronger cravings, missed treatment or movement toward opioid access can be reasons for clinical reassessment.
Depending on the individual situation, the treatment team may need to review:
- current opioid cravings;
- medication adherence;
- recent missed doses;
- treatment attendance;
- mental-health symptoms;
- pain;
- sleep;
- alcohol or other substance use;
- new environmental triggers;
- contact with previous opioid suppliers;
- overdose risk;
- whether the current level of care is still appropriate.
Medication Problems Can Be Important When Relapse Risk Suddenly Increases
FDA-approved medications for opioid use disorder include buprenorphine, methadone and naltrexone.
CDC states that medication treatment for OUD is associated with reduced overdose risk and overall mortality.
Cravings or Missed Treatment
If cravings have increased or doses have been missed, contact the prescribing clinician rather than adjusting treatment independently.
Do Not Change the Dose Yourself
Contact the opioid treatment program if treatment has been interrupted or cravings are becoming difficult to manage.
Know the Treatment Status
If antagonist treatment has ended, is delayed or its coverage is uncertain, discuss this promptly with the treatment provider.
Medication changes should be handled with the treating clinician.
Read: Medication for Opioid Relapse Prevention: What Are the Options? .
A Strong Craving Does Not Require an Immediate Decision About Opioids
A craving can create urgency. It can make the next few minutes feel as though they require a decision.
The first goal is often to delay action while changing the environment and increasing support.
Ask what is happening around the craving:
- Did a particular person trigger it?
- Are you somewhere associated with previous opioid use?
- Are you experiencing pain?
- Have you slept poorly?
- Did an argument or stressful event happen?
- Have you been drinking alcohol or using another substance?
- Have you missed treatment?
- Have you been isolated for a long period?
- Are depression or anxiety worsening?
Identifying what changed can help determine what needs to change next.
Reduce Immediate Opportunities to Obtain Opioids
Relapse risk becomes more difficult to manage when strong cravings and easy opioid access occur together.
Where practical and voluntary, consider steps that increase the time and effort required to reach opioids while you obtain treatment support.
Leave High-Risk Locations
Move away from places strongly associated with obtaining or using opioids.
End Contact With Suppliers
Do not continue conversations that are moving toward opioid access.
Stay Around Safe People
When relapse feels close, supportive company may provide additional time to reconnect with treatment.
Use the Existing Recovery Plan
Follow any agreed arrangements for managing access, money, transport or high-risk environments rather than improvising during a craving.
Make Sure Naloxone Is Available Before an Emergency Happens
CDC recommends naloxone and overdose education for people with opioid use disorder and their household members or significant others.
This is particularly important after detox, rehab or another period of reduced opioid exposure because opioid tolerance can decline.
Keep naloxone somewhere accessible rather than somewhere difficult to reach during an emergency.
People close to the person at risk should know where it is and how to use it.
Read: Opioid Tolerance After Detox: Why Overdose Risk Can Increase .
Some Relapse Warning Signs Need More Than a Coping Strategy
A mild passing thought about opioids is different from actively moving toward opioid use.
Seek urgent professional treatment support when risk is becoming difficult to interrupt.
| Situation | Response |
|---|---|
| Cravings are stronger but you remain connected with treatment. | Use the relapse-prevention plan and contact the treatment team to review the increase in cravings. |
| You are contacting previous opioid suppliers. | Stop the contact where possible, move toward supportive people and notify the treatment team promptly. |
| You have obtained opioids or are actively arranging to obtain them. | Treat this as a substantial increase in risk and seek urgent professional treatment support. |
| You have already used opioids. | Overdose safety becomes the immediate priority, followed by rapid reconnection with treatment. |
| Someone cannot be awakened or has very slow or stopped breathing. | Administer naloxone if available and contact emergency services immediately. |
In the United States, call or text 988 for crisis support. If there is immediate danger or an overdose is suspected, call emergency services.
The Priority Changes From Preventing Use to Preventing Harm and Reconnecting Treatment
Once opioid use has occurred, do not spend the first moments deciding whether the episode should be called a slip, lapse or relapse.
Immediate safety matters more.
If someone cannot be awakened, is unable to speak, has very slow or stopped breathing, or overdose is otherwise suspected, administer naloxone if available and contact emergency services immediately.
SAMHSA identifies unresponsiveness, slowed or stopped breathing, blue or purple lips or fingernails, limpness, vomiting and gurgling sounds among possible overdose signs.
After immediate safety has been addressed, reconnect with the treatment provider promptly rather than waiting for another episode of opioid use.
Once the Immediate Risk Has Passed, Review What Nearly Led to Opioid Use
A near-relapse can provide useful information about weaknesses in the current recovery plan.
Identify the first warning sign
Look earlier than the strongest craving. What changed first?
Identify the trigger
Was the main driver stress, pain, contact with someone, money, loneliness, conflict or another situation?
Review medication
Ask whether treatment was being received as planned and whether clinical reassessment is needed.
Review treatment engagement
Look for missed counselling, medical appointments or reduced contact with recovery support.
Change the environment
Reduce avoidable exposure to whichever people, places or circumstances were involved.
Rewrite the emergency plan
Make the next response more specific: who to call, where to go, what to leave and what treatment contact to use.
Evidence-Based Medication May Be Part of Preventing the Next High-Risk Episode
FDA-approved medications for opioid use disorder include buprenorphine, methadone and naltrexone.
Buprenorphine
Can reduce opioid withdrawal and cravings as part of continuing OUD treatment.
Methadone
Can reduce withdrawal and cravings and support ongoing treatment for opioid use disorder.
Naltrexone
Blocks opioid receptors and requires an appropriate opioid-free period before initiation.
Medication choice should be individualized rather than changed in response to one difficult day without medical guidance.
Read: Medication for Opioid Relapse Prevention: What Are the Options? .
How Can Family Help When Someone Says They Feel Close to Relapse?
If someone tells you that they feel close to using opioids, take the disclosure seriously without automatically turning it into an interrogation.
Stay Focused on the Immediate Risk
Ask what is happening now rather than immediately revisiting every previous relapse.
Help Contact Treatment
Offer practical assistance connecting with the clinician, counsellor or treatment program.
Help Change the Environment
If appropriate, help the person move away from a high-risk location or contact.
Keep Naloxone Available
Know where naloxone is and how to respond if opioid overdose occurs.
Feeling Close to Relapse Does Not Mean You No Longer Want Recovery
Someone can strongly want recovery and still experience intense cravings, stress responses or conditioned opioid-related thoughts.
Recognising that risk is increasing and asking for help can itself be a recovery behaviour.
Read: Why People Relapse Even When They Really Want to Stop .
Create the Response Before the Next High-Risk Moment
The wider opioid relapse-prevention strategy can include medication, treatment continuity, craving management, trigger planning, mental-health care, family support, naloxone, environmental changes and a clear response when warning signs begin appearing.
Discuss a Longer-Term Relapse-Prevention Strategy
DeBinge provides addiction treatment in Nassau, The Bahamas. For appropriately assessed patients, treatment may include long-acting implant-based naltrexone alongside counselling and continuing recovery planning.
A longer-acting antagonist approach may reduce reliance on repeated medication-taking decisions, but it does not replace counselling, mental-health care, craving management, family support or a wider relapse-prevention plan.
Treatment suitability depends on current opioid exposure, completion of an appropriate opioid-free period, medical history, previous treatment, medications and individual recovery needs.
What to Do When Opioid Relapse Feels Close: FAQs
What should I do when I feel like I am going to relapse on opioids?
Act early. Leave immediate triggers where possible, tell a trusted person, contact your treatment provider or recovery support, follow your prescribed medication plan and make sure naloxone is available. If you are actively arranging to obtain opioids or feel unable to interrupt the situation, seek urgent professional treatment support.
What are warning signs that opioid relapse may be getting closer?
Possible warning signs include stronger cravings, missed treatment, increasing isolation, renewed contact with previous opioid networks, returning to high-risk places, romanticising previous use or actively looking for opioids.
Does a strong opioid craving mean I will relapse?
No. A strong craving does not make relapse inevitable. It is a reason to use the relapse-prevention plan, change the immediate environment and increase treatment or recovery support.
Should I tell someone if I am thinking about using opioids again?
Yes. Telling a trusted support person or treatment provider can bring more support into the situation before opioid use occurs.
Should I contact my treatment provider before I actually relapse?
Yes. Increasing cravings, missed medication, renewed contact with opioid suppliers or other meaningful changes in risk can justify clinical reassessment before opioid use happens.
Should I change my medication if opioid cravings suddenly increase?
Do not independently stop, restart, double or change prescribed OUD medication. Contact the treating clinician to review increased cravings or missed treatment.
Should naloxone be available when relapse risk is high?
Yes. Where opioid exposure remains possible, naloxone and overdose-response education should remain part of the safety plan.
Why can relapse after detox be especially dangerous?
Opioid tolerance may decrease during abstinence. A previously tolerated amount may therefore cause much stronger respiratory depression or overdose after detox or another period without opioids.
What if I already used opioids?
Immediate overdose safety comes first. If overdose is suspected, administer naloxone if available and contact emergency services. Once immediate safety has been addressed, reconnect with treatment promptly.
Does feeling close to relapse mean treatment has failed?
No. Rising relapse risk can indicate that treatment, medication, environment, mental-health care or other recovery supports need reassessment. Recognising the warning signs early creates an opportunity to strengthen the plan.
Can medication reduce opioid relapse risk?
Evidence-based medications for opioid use disorder include buprenorphine, methadone and naltrexone. Treatment should be selected according to individual clinical circumstances.
Are naltrexone implants FDA-approved in the United States?
No. Naltrexone implant formulations are not FDA-approved for routine clinical use in the United States.
Evidence Used in This Guide
CDC — Opioid Use Disorder: Treating
CDC clinical guidance on medications for opioid use disorder, overdose reduction, naloxone and the risks of detoxification without ongoing medication treatment.
CDC — Treatment of Opioid Use Disorder
CDC information for patients and families on OUD as a treatable medical condition, medication treatment, recovery support and naloxone.
CDC — Recovery Is Possible: Treatment for Opioid Addiction
CDC guidance on continuing opioid-use-disorder treatment, medications, behavioural support and the role of loved ones in recovery.
SAMHSA — How to Cope
SAMHSA guidance on reaching out for support, coping with mental-health and substance-use problems and obtaining crisis support when necessary.
SAMHSA — Opioid Overdose Prevention and Reversal
SAMHSA guidance on recognising opioid overdose, emergency action and the use of opioid overdose reversal medication.
CDC — Naloxone
CDC information on naloxone, opioid overdose recognition and emergency response.
Relapse risk is individual and cannot be predicted from a single behaviour or craving. Clinical guidance, treatment availability and regulatory information can change.
Prepared for Medical Review
Dr Fergus Law, BSc, MBChB, FRCPsych
Consultant Psychiatrist specialising in substance misuse and addiction psychiatry.
This article has been prepared as an educational resource concerning opioid relapse warning signs, cravings, continuing treatment, overdose prevention and early intervention. It is awaiting formal clinical approval.
View Dr Fergus Law’s professional profile
This Article Does Not Replace Emergency or Individual Medical Care
This page provides general educational information. It does not diagnose opioid use disorder, determine an individual’s relapse probability or replace assessment by an appropriately qualified healthcare professional.
Do not independently stop, restart, increase, reduce or otherwise change methadone, buprenorphine, naltrexone or another prescribed medication based on this article.
Naltrexone requires appropriate opioid-free preparation before initiation. Starting naltrexone while significant opioid physical dependence remains can precipitate withdrawal.
If someone cannot be awakened, has very slow or stopped breathing, or opioid overdose is suspected, administer naloxone if available and contact local emergency services immediately.
If you are experiencing suicidal thoughts, believe you may intentionally overdose or cannot keep yourself safe, seek emergency or crisis support immediately. In the United States, call or text 988. In an immediate emergency, contact local emergency services.
DeBinge is located in Nassau, The Bahamas. We do not operate a treatment facility in the United States. Naltrexone implant formulations are not FDA-approved for routine clinical use in the United States.